Genetic basis of apnoea of prematurity and caffeine treatment response: Role of adenosine receptor polymorphisms: Genetic basis of apnoea of prematurity

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 7, 2012, Pages

  Kumral, Abdullah ^a   Tuzun, Funda ^a   Yesilirmak, Didem Cemile ^a   Duman, Nuray ^a   Ozkan, Hasan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Adenosine receptors; Apnoea; Bronchopulmonary dysplasia; Caffeine; Polymorphism

Indexed keywords

ADENOSINE 2A RECEPTOR; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR; CAFFEINE CITRATE; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; GENOTYPE; GESTATIONAL AGE; HUMAN; HYPERTENSION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN APNEA; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TACHYCARDIA; TREATMENT RESPONSE; UMBILICAL CORD BLOOD;

BRONCHOPULMONARY DYSPLASIA; CAFFEINE; CASE-CONTROL STUDIES; CITRATES; DRUG ADMINISTRATION SCHEDULE; GENETIC MARKERS; GENOTYPE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LOGISTIC MODELS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PURINERGIC P1 RECEPTOR ANTAGONISTS; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 84861808021     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2012.02664.x     Document Type: Article

References (27)

1. Abu-Shaweesh JM, Martin RJ,. Neonatal apnea: what's new? Pediatr Pulmonol 2008; 43: 937-44.
2. Zhao J, Gonzalez F, Mu D,. Apnea of prematurity: from cause to treatment. Eur J Pediatr 2011; 170: 1097-105.
3. Henderson-Smart DJ, Steer PA,. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 2009; 20: CD000273.
4. Natarajan G, Botica ML, Thomas R, Aranda JV,. Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics 2007; 119: 936-40.
5. Tamim H, Khogali M, Beydoun H, Melki I, Yunis K,. Consanguinity and apnea of prematurity. Am J Epidemiol 2003; 158: 942-6.
6. Bloch-Salisbury E, Hall MH, Sharma P, Boyd T, Bednarek F, Paydarfar D,. Heritability of apnea of prematurity: a retrospective twin study. Pediatrics 2010; 126: e779-87.
7. Rogers PJ, Hohoff C, Heatherley SV, Mullings EL, Maxfield PJ, Evershed RP, et al., Association of the anxiogenic and alerting effects of caffeine with adora2a and adora1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 2010; 35: 1973-83.
8. Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H,. Association between adora2a and drd2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2008; 33: 2791-800.
9. Alsene K, Deckert J, Sand P, de WitH,. Association between a2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003; 28: 1694-702.
10. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al., Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354: 2112-21.
11. Keszler M,. State of the art in conventional mechanical ventilation. J Perinatol 2009; 29: 262-75.
12. American Academy of Pediatrics. Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 2003; 111: 914-7.
13. Whitley E, Ball J,. Statistics review 4: sample size calculations. Crit Care 2002; 6: 335-41.
14. Cornelis MC, El-Sohemy A, Campos H,. Genetic polymorphism of the adenosine a2a receptor is associated with habitual caffeine consumption. Am J Clin Nutr 2007; 86: 240-4.
15. Hohoff C, McDonald JM, Baune BT, Cook EH, Deckert J, de Wit H,. Interindividual variation in anxiety response to amphetamine: possible role for adenosine a2a receptor gene variants. Am J Med Genet B Neuropsychiatr Genet 2005; 139: 42-4.
16. Kobayashi H, Ujike H, Iwata N, Inada T, Yamada M, Sekine Y, et al., Association analysis of the adenosine a1 receptor gene polymorphisms in patients with methamphetamine dependence/psychosis. Curr Neuropharmacol 2011; 9: 137-42.
17. Kendler KS, Prescott CA,. Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. Am J Psychiatry 1999; 156: 223-8.
18. Aden U, Herlenius E, Tang LQ, Fredholm BB,. Maternal caffeine intake has minor effects on adenosine receptor ontogeny in the rat brain. Pediatr Res 2000; 48: 177-83.
19. Herlenius E, Aden U, Tang LQ, Lagercrantz H,. Perinatal respiratory control and its modulation by adenosine and caffeine in the rat. Pediatr Res 2002; 51: 4-12.
20. Parker RA, Lindstrom DP, Cotton RB,. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 1996; 20: 206-9.
21. Bhandari V, Gruen JR,. The genetics of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 185-91.
22. Davis PG, Schmidt B, Roberts RS, Doyle LW, Asztalos E, Haslam R, et al., Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr 2010; 156: 382-7.
23. Kim SH, Kim YK, Park HW, Ye YM, Min KU, Park HS,. Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir Med 2009; 103: 356-63.
24. Nadeem A, Fan M, Ansari HR, Ledent C, Jamal Mustafa S,. Enhanced airway reactivity and inflammation in a2a adenosine receptor-deficient allergic mice. Am J Physiol Lung Cell Mol Physiol 2007; 292: 1335-44.
25. Fozard JR, Ellis KM, Villela Dantas MF, Tigani B, Mazzoni L,. Effects of cgs 21680, a selective adenosine a2a receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol 2002; 438: 183-8.
26. Mustafa SJ, Nadeem A, Fan M, Zhong H, Belardinelli L, Zeng D,. Effect of a specific and selective a(2b) adenosine receptor antagonist on adenosine agonist amp and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 2007; 320: 1246-51.
27. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G,. Neutrophil adherence to endothelium is enhanced via adenosine a1 receptors and inhibited via adenosine a2 receptors. J Immunol 1992; 148: 2201-6.